Daito Pharmaceutical Co.,Ltd. (TYO:4577)
Japan · Delayed Price · Currency is JPY 1,348.00
+4.00 (0.30%)
Jan 21, 2026, 3:30 PM JST
Daito Pharmaceutical Cash Flow Statement
Financials in millions JPY. Fiscal year is June - May.
Millions JPY. Fiscal year is Jun - May.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Nov '25 Nov 30, 2025 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 | May '21 May 31, 2021 | 2016 - 2020 |
Net Income | 2,913 | 2,958 | 4,218 | 5,076 | 6,720 | 5,873 | Upgrade |
Depreciation & Amortization | 4,359 | 4,332 | 3,659 | 3,870 | 3,313 | 3,154 | Upgrade |
Loss (Gain) From Sale of Assets | 416 | 384 | 165 | 17 | 56 | 315 | Upgrade |
Loss (Gain) From Sale of Investments | -102 | -409 | -326 | 87 | -47 | -1 | Upgrade |
Loss (Gain) on Equity Investments | 47 | -75 | - | - | - | - | Upgrade |
Other Operating Activities | -320 | -571 | -1,111 | -2,405 | -1,820 | -1,955 | Upgrade |
Change in Accounts Receivable | -343 | -4,891 | 2,221 | -1,502 | -3,299 | 2,723 | Upgrade |
Change in Inventory | 3,152 | 2,419 | -2,640 | -1,413 | -1,041 | -3,609 | Upgrade |
Change in Accounts Payable | -1,078 | -360 | 802 | 538 | 22 | -765 | Upgrade |
Change in Other Net Operating Assets | 355 | 2,110 | -1,806 | -113 | 466 | -553 | Upgrade |
Operating Cash Flow | 9,399 | 5,897 | 5,182 | 4,155 | 4,370 | 5,182 | Upgrade |
Operating Cash Flow Growth | 85.17% | 13.80% | 24.72% | -4.92% | -15.67% | 20.34% | Upgrade |
Capital Expenditures | -3,989 | -6,789 | -6,220 | -5,505 | -4,627 | -6,318 | Upgrade |
Sale of Property, Plant & Equipment | -96 | -65 | - | - | - | - | Upgrade |
Cash Acquisitions | - | -707 | - | - | - | - | Upgrade |
Sale (Purchase) of Intangibles | -616 | -241 | -56 | -51 | -106 | -31 | Upgrade |
Investment in Securities | 163 | 438 | 335 | - | 256 | 5 | Upgrade |
Other Investing Activities | 130 | -1 | 11 | -10 | 77 | 20 | Upgrade |
Investing Cash Flow | -4,408 | -7,365 | -5,930 | -5,566 | -4,400 | -6,324 | Upgrade |
Long-Term Debt Issued | - | 6,000 | 4,000 | 3,000 | 1,500 | 2,000 | Upgrade |
Total Debt Issued | - | 6,000 | 4,000 | 3,000 | 1,500 | 2,000 | Upgrade |
Long-Term Debt Repaid | - | -3,099 | -2,029 | -1,638 | -1,444 | -1,713 | Upgrade |
Total Debt Repaid | -3,299 | -3,099 | -2,029 | -1,638 | -1,444 | -1,713 | Upgrade |
Net Debt Issued (Repaid) | -3,299 | 2,901 | 1,971 | 1,362 | 56 | 287 | Upgrade |
Issuance of Common Stock | - | - | - | 302 | 1,527 | 1,798 | Upgrade |
Repurchase of Common Stock | -1,227 | -623 | -1,176 | -110 | - | - | Upgrade |
Common Dividends Paid | -1,061 | -998 | -907 | -931 | -660 | -658 | Upgrade |
Other Financing Activities | -374 | -278 | -71 | -7 | 66 | -3 | Upgrade |
Financing Cash Flow | -5,961 | 1,002 | -183 | 616 | 989 | 1,424 | Upgrade |
Foreign Exchange Rate Adjustments | -48 | -54 | 51 | 20 | 48 | 5 | Upgrade |
Miscellaneous Cash Flow Adjustments | 1 | 1 | 1 | 1 | 1 | 1 | Upgrade |
Net Cash Flow | -1,017 | -519 | -879 | -774 | 1,008 | 288 | Upgrade |
Free Cash Flow | 5,410 | -892 | -1,038 | -1,350 | -257 | -1,136 | Upgrade |
Free Cash Flow Margin | 10.57% | -1.76% | -2.21% | -2.99% | -0.59% | -2.33% | Upgrade |
Free Cash Flow Per Share | 180.05 | -29.32 | -33.08 | -42.65 | -8.39 | -37.82 | Upgrade |
Cash Interest Paid | 134 | 126 | 40 | 13 | 9 | 7 | Upgrade |
Cash Income Tax Paid | 614 | 842 | 1,265 | 2,411 | 1,924 | 2,088 | Upgrade |
Levered Free Cash Flow | 3,394 | -4,444 | 330.13 | -918 | -406.63 | -2,781 | Upgrade |
Unlevered Free Cash Flow | 3,478 | -4,367 | 355.75 | -910.5 | -401 | -2,776 | Upgrade |
Change in Working Capital | 2,086 | -722 | -1,423 | -2,490 | -3,852 | -2,204 | Upgrade |
Updated Nov 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.